{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:49:29Z","timestamp":1791805769836,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.ejpb.2005.03.004","type":"journal-article","created":{"date-parts":[[2005,6,5]],"date-time":"2005-06-05T07:15:02Z","timestamp":1117955702000},"page":"167-178","source":"Crossref","is-referenced-by-count":347,"title":["The human epidermis models EpiSkin\u00ae, SkinEthic\u00ae and EpiDerm\u00ae: An evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport"],"prefix":"10.1016","volume":"60","author":[{"given":"Frank","family":"Netzlaff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-M.","family":"Lehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.W.","family":"Wertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.F.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2005.03.004_bib1","series-title":"Cosmetic Ingredients: Guidelines for Percutaneous Absorption\/Penetration","author":"COLIPA","year":"1995"},{"key":"10.1016\/j.ejpb.2005.03.004_bib2","unstructured":"OECD, Skin absorption: in vitro Method, in Draft Test Guideline 428, 2002."},{"key":"10.1016\/j.ejpb.2005.03.004_bib3","unstructured":"OECD, Draft Guidance Document for the Conduct of Skin Absorption Studies, in OECD Series on Testing and Assessment, 2002."},{"key":"10.1016\/j.ejpb.2005.03.004_bib4","article-title":"Dermal absorbtion and toxicity assessment","volume":"vol. 91","author":"Roberts","year":"1998"},{"issue":"4","key":"10.1016\/j.ejpb.2005.03.004_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/1523-1747.ep12471781","article-title":"Composition and morphology of epidermal cyst lipids","volume":"89","author":"Wertz","year":"1987","journal-title":"J. Invest. Dermatol."},{"issue":"Suppl. 15","key":"10.1016\/j.ejpb.2005.03.004_bib6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000066682","article-title":"Characterization of reconstructed skin models","volume":"1","author":"Ponec","year":"2002","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"issue":"4","key":"10.1016\/j.ejpb.2005.03.004_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/1523-1747.ep12555510","article-title":"Terminal epidermal differentiation of human keratinocytes grown in chemically defined medium on inert filter substrates at the air\u2013liquid interface","volume":"95","author":"Rosdy","year":"1990","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.ejpb.2005.03.004_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/1523-1747.ep12336024","article-title":"The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C","volume":"109","author":"Ponec","year":"1997","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.ejpb.2005.03.004_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2133.1993.tb11839.x","article-title":"Production of basement membrane components by a reconstructed epidermis cultured in the absence of serum and dermal factors","volume":"129","author":"Rosdy","year":"1993","journal-title":"Br. J. Dermatol."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2005.03.004_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0378-5173(00)00459-2","article-title":"Lipid and ultrastructural characterization of reconstructed skin models","volume":"203","author":"Ponec","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2005.03.004_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0925-4439(93)90135-N","article-title":"Ceramide composition of the psoriatic scale","volume":"1182","author":"Motta","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.ejpb.2005.03.004_bib12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/1523-1747.ep12265510","article-title":"The composition of the ceramides from human stratum corneum and from comedones","volume":"84","author":"Wertz","year":"1985","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.ejpb.2005.03.004_bib13","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0022-2275(20)39952-1","article-title":"6-Hydroxy-4-sphingenine in human epidermal ceramides","volume":"35","author":"Robson","year":"1994","journal-title":"J. Lipid. Res."},{"issue":"8","key":"10.1016\/j.ejpb.2005.03.004_bib14","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0022-2275(20)33385-X","article-title":"A new 6-hydroxy-4-sphingenine-containing ceramide in human skin","volume":"40","author":"Stewart","year":"1999","journal-title":"J. Lipid. Res."},{"issue":"Suppl. 15","key":"10.1016\/j.ejpb.2005.03.004_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000066682","article-title":"Characterization of reconstructed skin models","volume":"1","author":"Ponec","year":"2002","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"issue":"3","key":"10.1016\/j.ejpb.2005.03.004_bib16","first-page":"495","article-title":"Immunohistochemical expression of SKALP\/elafin in squamous cell carcinoma of human lung","volume":"9","author":"Yoshida","year":"2002","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.ejpb.2005.03.004_bib17","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1523-1747.1999.00602.x","article-title":"Expression of differentiation markers during fetal skin development in humans: immunohistochemical studies on the precursor proteins forming the cornified cell envelope","volume":"112","author":"Lee","year":"1999","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.ejpb.2005.03.004_bib18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2340\/00015555808993","article-title":"Characterization and comparison of reconstructed skin models: morphological and immunohistochemical evaluation","volume":"80","author":"Boelsma","year":"2000","journal-title":"Acta Derm. Venereol."},{"issue":"4","key":"10.1016\/j.ejpb.2005.03.004_bib19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14573\/altex.1997.4.165","article-title":"Development of a new in vitro test for dermal phototoxicity using a model of reconstituted human epidermis","volume":"14","author":"Liebsch","year":"1997","journal-title":"Altex"},{"issue":"6","key":"10.1016\/j.ejpb.2005.03.004_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1023\/A:1007604612003","article-title":"Development of a highly sensitive in vitro phototoxicity assay using the SkinEthic reconstructed human epidermis","volume":"16","author":"Bernard","year":"2000","journal-title":"Cell. Biol. Toxicol."},{"issue":"3","key":"10.1016\/j.ejpb.2005.03.004_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/109793301753407920","article-title":"Assessment of the phototoxic potential of compounds and finished topical products using a human reconstructed epidermis","volume":"14","author":"Medina","year":"2001","journal-title":"In Vitro Mol. Toxicol."},{"issue":"4","key":"10.1016\/j.ejpb.2005.03.004_bib22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0887-2333(03)00048-1","article-title":"An assessment of the phototoxic hazard of a personal product ingredient using in vitro assays","volume":"17","author":"Jones","year":"2003","journal-title":"Toxicol. In Vitro"},{"issue":"2","key":"10.1016\/j.ejpb.2005.03.004_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1007577515215","article-title":"Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles","volume":"15","author":"de Brugerolle de","year":"1999","journal-title":"Cell Biol. Toxicol."},{"issue":"Suppl. 15","key":"10.1016\/j.ejpb.2005.03.004_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000066678","article-title":"Reconstructed skin kits: reproducibility of cutaneous irritancy testing","volume":"1","author":"Faller","year":"2002","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"issue":"3","key":"10.1016\/j.ejpb.2005.03.004_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0887-2333(03)00019-5","article-title":"Analysis of interleukin-1alpha (IL-1alpha) and interleukin-8 (IL-8) expression and release in in vitro reconstructed human epidermis for the prediction of in vivo skin irritation and\/or sensitization","volume":"17","author":"Coquette","year":"2003","journal-title":"Toxicol. In Vitro"},{"issue":"Suppl. 15","key":"10.1016\/j.ejpb.2005.03.004_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000066679","article-title":"Permeation and skin absorption: reproducibility of various industrial reconstructed human skin models","volume":"1","author":"Lotte","year":"2002","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"issue":"1-2","key":"10.1016\/j.ejpb.2005.03.004_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-5173(00)00665-7","article-title":"Comparison of human skin or epidermis models with human and animal skin in in vitro percutaneous absorption","volume":"215","author":"Schmook","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2005.03.004_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1467-2494.1998.181621.x","article-title":"o\/w emulsion and w\/o\/w multiple emulsion: physical characterization and skin pharmacokinetic comparison in the delivery process of caffeine","volume":"20","author":"Doucet","year":"1998","journal-title":"Int. J. Cosm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2005.03.004_bib29","first-page":"3","article-title":"Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin","volume":"20","author":"Haberland","year":"2003","journal-title":"Altex"},{"issue":"2","key":"10.1016\/j.ejpb.2005.03.004_bib30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0014-4827(91)90102-Z","article-title":"In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute","volume":"193","author":"Tinois","year":"1991","journal-title":"Exp. Cell. Res."},{"issue":"2","key":"10.1016\/j.ejpb.2005.03.004_bib31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0887-2333(94)90195-3","article-title":"Episkin, a reconstituted human epidermis for assessing in vitro the irritancy of topically applied compounds","volume":"8","author":"Roguet","year":"1993","journal-title":"Toxicol. In Vitro"},{"issue":"4","key":"10.1016\/j.ejpb.2005.03.004_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/1523-1747.ep12526137","article-title":"Percutaneous transport in relation to stratum corneum structure and lipid composition","volume":"76","author":"Elias","year":"1981","journal-title":"J. Inv. Dermatol."},{"issue":"2","key":"10.1016\/j.ejpb.2005.03.004_bib33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0022-2275(20)38005-6","article-title":"Human stratum corneum lipids: characterization and regional variations","volume":"24","author":"Lampe","year":"1983","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.ejpb.2005.03.004_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-2275(20)38401-7","article-title":"Lipid content and lipid type as determinants of the epidermal permeability barrier","volume":"30","author":"Grubauer","year":"1989","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.ejpb.2005.03.004_bib35","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1023\/A:1016047816699","article-title":"Stratum corneum lipids of human epidermal keratinocyte air\u2013liquid cultures: implications for barrier function","volume":"13","author":"Kennedy","year":"1996","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ejpb.2005.03.004_bib36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1034\/j.1600-0781.2002.180207.x","article-title":"Use of human reconstituted epidermis Episkin for assessment of weak phototoxic potential of chemical compounds","volume":"18","author":"Portes","year":"2002","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"5","key":"10.1016\/j.ejpb.2005.03.004_bib37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/1523-1747.ep12319895","article-title":"Epidermal damage induced by irritants in man: a light and electron microscopic study","volume":"93","author":"Willis","year":"1989","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.ejpb.2005.03.004_bib38","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0887-2333(94)90033-7","article-title":"The use of in vitro reconstituted human skin in dermotoxicity testing","volume":"8","author":"Roguet","year":"1994","journal-title":"Toxicol. In Vitro"},{"issue":"4-5","key":"10.1016\/j.ejpb.2005.03.004_bib39","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0887-2333(01)00036-4","article-title":"Generation of oxidative stress in human cutaneous models following in vitro ozone exposure","volume":"15","author":"Cotovio","year":"2001","journal-title":"Toxicol. In Vitro"},{"issue":"5","key":"10.1016\/j.ejpb.2005.03.004_bib40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0887-2333(02)00053-X","article-title":"Predictive ability of reconstructed human epidermis equivalents for the assessment of skin irritation of cosmetics","volume":"16","author":"Faller","year":"2002","journal-title":"Toxicol. In Vitro: an international journal published in association with BIBRA"},{"issue":"6","key":"10.1016\/j.ejpb.2005.03.004_bib41","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0887-2333(02)00090-5","article-title":"Refinement of the Episkin protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study","volume":"16","author":"Portes","year":"2002","journal-title":"Toxicol. In Vitro"},{"issue":"Suppl. 15","key":"10.1016\/j.ejpb.2005.03.004_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000066680","article-title":"Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or alpha-tocopherol applied on human skin models or human skin ex vivo at finite doses","volume":"1","author":"Dreher","year":"2002","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"issue":"Suppl. 15","key":"10.1016\/j.ejpb.2005.03.004_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000066683","article-title":"Improvement of the experimental setup to assess cutaneous bioavailability on human skin models: dynamic protocol","volume":"1","author":"Dreher","year":"2002","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"key":"10.1016\/j.ejpb.2005.03.004_bib44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0887-2333(98)00019-8","article-title":"The ECVAM international validation study on in vitro tests for skin corrosivity. 2. Results and evaluation by the Management Team","volume":"12","author":"Fentem","year":"1998","journal-title":"Toxicol. In Vitro"},{"issue":"4","key":"10.1016\/j.ejpb.2005.03.004_bib45","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0887-2333(94)90095-7","article-title":"New epidermal model for dermal irritancy testing","volume":"8","author":"Cannon","year":"1994","journal-title":"Toxicol. In Vitro"},{"issue":"3","key":"10.1016\/j.ejpb.2005.03.004_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1600-0625.2001.110304.x","article-title":"Effect of skin barrier competence on SLS and water-induced IL-1alpha expression","volume":"11","author":"Gibbs","year":"2002","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.ejpb.2005.03.004_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0887-2333(01)00002-9","article-title":"A prevalidation study on in vitro tests for acute skin irritation. Results and evaluation by the Management Team","volume":"15","author":"Fentem","year":"2001","journal-title":"Toxicol. In Vitro"},{"issue":"2","key":"10.1016\/j.ejpb.2005.03.004_bib48","first-page":"103","article-title":"Reconstructed skin equivalents for assessing percutaneous drug absorption from pharmaceutical formulations","volume":"18","author":"Zghoul","year":"2001","journal-title":"Altex"},{"issue":"3","key":"10.1016\/j.ejpb.2005.03.004_bib49","first-page":"150","article-title":"Validation of in vitro tests for skin corrosivity","volume":"16","author":"Fentem","year":"1999","journal-title":"Altex"},{"issue":"1","key":"10.1016\/j.ejpb.2005.03.004_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s004410050680","article-title":"Impaired desquamation in the in vitro reconstructed human epidermis","volume":"286","author":"Vicanov\u00e2a","year":"1996","journal-title":"Cell Tissue Res."},{"issue":"3","key":"10.1016\/j.ejpb.2005.03.004_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/1523-1747.ep12465212","article-title":"Barrier function of human keratinocyte cultures grown at the air\u2013liquid interface","volume":"96","author":"Mak","year":"1991","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.ejpb.2005.03.004_bib52","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/1523-1747.ep12485073","article-title":"Full-thickness human skin explants for testing the toxicity of topically applied chemicals","volume":"95","author":"Nakamura","year":"1990","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2005.03.004_bib53","unstructured":"K.B. Brain, K.A. Walters, A.C. Wattkinson, Investigation of permeation in vitro, in: M.S. Roberts, K.A Walters (Eds.), Dermal Absorbtion and Toxicity Assessment, vol. 91, in: J. Swarbrick (Ed.), Drugs and the Pharmaceutical Sciences, 1998, Marcel Dekker, Inc., Wilmington, NC."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641105001116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641105001116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T07:22:51Z","timestamp":1706253771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641105001116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0939641105001116"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2005.03.004","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}